Neurocognitive disorders: Cluster 1 of the proposed meta-structure for DSM-V and ICD-11

Psychological Medicine

Volumn 39, Issue 12, 2009, Pages 2001-2012

  Sachdev, P ^a   Andrews, G ^a   Hobbs, M J ^a   Sunderland, M ^a   Anderson, T M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Classification; Delirium; Dementia; DSM V; ICD 11; Mild cognitive impairment; Neurocognitive disorders

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

ALZHEIMER DISEASE; AMNESIA; BRAIN DEVELOPMENT; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DELIRIUM; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DISEASE MARKER; ELECTROENCEPHALOGRAM; EMOTION; ENVIRONMENTAL FACTOR; HUMAN; MEDICAL LITERATURE; NEUROBIOLOGY; REVIEW; RISK FACTOR; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; AMNESIA; BIPOLAR DISORDER; COGNITION DISORDERS; COMORBIDITY; DELIRIUM; DEMENTIA; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE PROGRESSION; HUMANS; INTELLIGENCE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OBSESSIVE-COMPULSIVE DISORDER; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TERMINOLOGY AS TOPIC;

EID: 70449644720     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291709990262     Document Type: Review

References (94)

1. Alexopoulos GS (2003). Vascular disease, depression, and dementia. Journal of the American Geriatrics Society 51, 1178-1180.
2. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997). 'Vascular depression' hypothesis. Archives of General Psychiatry 54, 915-922.
3. Andrews G, Goldberg DP, Krueger RF, Carpenter Jr. WT, Hyman SE, Sachdev, P, Pine DS (2009a). Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity? Psychological Medicine. doi:10.1017/S0033291709990250.
4. Andrews G, Pine DS, Hobbs MJ, Anderson TM, Sunderland M (2009b). Neurodevelopmental disorders: Cluster 2 of the proposed meta-structure for DSM-V and ICD-11. Psychological Medicine. doi:10.1017/ S0033291709990274.
5. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC.
6. Armstrong RA, Lantos PL, Cairns, NJ (2005). Overlap between neurodegenerative disorders. Neuropathology 25, 111-124.
7. Ashburner J, Csernansky JG, Davatzikos C, Fox NC, Frisoni GB, Thompson PM (2003). Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurology 2, 79-86.
8. Beck AT (1975). Cognitive Therapy and the Emotional Disorders. International Universities Press: New York, NY.
9. Bleecker ML, Ford DP, Lindgren KN, Hoese VM, Walsh KS, Vaughan CG (2005). Differential effects of lead exposure on components of verbal memory. Occupational Environmental Medicine 62, 181-187.
10. Boutros NN, Struve F (2002). Electrophysiological stageing of Alzheimer-related changes. Acta Neuropathologica 82, 239-259.
11. Braak H, Braak E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 82, 239-259.
12. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004). Stages in the development of Parkinson's disease-related pathology. Cell and Tissue Research 318, 121-134.
13. Brookmeyer R, Corrada MM, Curriero FC, Kawas C (2002). Survival following a diagnosis of Alzheimer disease. Archives of Neurology 59, 1764-1767.
14. Burns A, Gallagley A, Byrne J (2004). Delirium. Journal of Neurology, Neurosurgery and Psychiatry 75, 362-367.
15. Caspi A, McCray J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R (2002). Role of genotype in the cycle of violence in maltreated children. Science 297, 851-854.
16. Caspi A, Moffitt TE (2006). Gene-environment interactions in psychiatry: joining forces with neuroscience. Nature Reviews Neuroscience 7, 583-590.
17. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
18. Chertkow H, Black S (2007). Imaging biomarkers and their role in dementia clinical trials. Canadian Journal of Neurological Sciences 34 (Suppl. 1), S77-S83.
19. Cole MG (2004). Delirium in elderly patients. American Journal of Geriatric Psychiatry 12, 7-21.
20. Coppus A, Evenhuis H, Verberne G-J, Visser F, van Gool P, Eikelenboom P, van Duijin C (2006). Dementia and mortality in persons with Down's syndrome. Journal of Intellectual Disability Research 50, 768-777.
21. Erkinjuntti T, Roman G, Gauthier S (2004). Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors. Journal of the Neurological Sciences 226, 63-66. (Pubitemid 39505408)
22. Ertekin-Taner N (2007). Genetics of Alzheimer's disease: a centennial review. Neurologic Clinics 25, 611-667.
23. Fick DM, Agostini JV, Inouye SK (2002). Delirium superimposed on dementia: a systematic review. Journal of the American Geriatrics Society 50, 1723-1732.
24. Green AJ (2002). Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease. Neuropathology and Applied Neurobiology 28, 427-440.
25. Gusella JF, MacDonald ME (1996). Trinucleotide instability: a repeating theme in human inherited disorders. Annual Review of Medicine 47, 201-209.
26. Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H (1998). Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathologica 96, 116-122.
27. Halliwell B (2006). Oxidative stress and neurodegeneration: where are we now? Journal of Neurochemistry 97, 1634-1658.
28. Harding A, Halliday G, Caine D, Kril J (2000). Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. Brain 123, 141-154.
29. Harper C (2007). The neurotoxicity of alcohol. Human and Experimental Toxicology 26, 251-257.
30. Harrison PJ (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122, 593-624.
31. Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois M-F (2000). Vascular dementia: incidence and risk factors in the Canadian Study of Health and Aging. Stroke 31, 1487-1493.
32. Hogan DB, Patterson C (2002). Progress in clinical neurosciences: Treatment of Alzheimer's disease and other dementias-review and comparison of the cholinesterase inhibitors. Canadian Journal of Neurological Sciences 29, 306-314.
33. Holland AJ, Hon J, Huppert FA, Stevens F (2000). Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. Journal of Intellectual Disability Research 44, 138-146.
34. Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
35. Ince PG (2001). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357, 169-175.
36. Inouye SK (1999). Predisposing and precipitating factors for delirium in hospitalized older patients. Dementia and Geriatric Cognitive Disorders 10, 393-400.
37. Inouye SK, Rushing JT, Foreman MD, Palmer RM, Pompei P (1998). Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. Journal of General Internal Medicine 13, 234-242.
38. Iregren A (2006). Behavioral toxicology: from historical background to future trends. Medicina del Lavoro 97, 332-338.
39. Jorm AF, Korten A, Henderson AS (1987). The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatrica Scandinavica 76, 465-479.
40. Kalaria RN, Ballard C (1999). Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Disease and Associated Disorders 13, S115-S123.
41. Katz R (2004). Biomarkers and surrogate markers: an FDA perspective. NeuroRx 1, 89-95.
42. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang G, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology 55, 306-319. (Pubitemid 38269583)
43. Kopelman MD (2002). Disorders of memory. Brain 125, 2152-2190.
44. Krueger RF (1999). The structure of common mental disorders. Archives of General Psychiatry 56, 921-926.
45. Krueger RF, Markon KE (2006). Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. Annual Reviews in Clinical Psychology 2, 111-133.
46. Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999). Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Annals of Neurology 46, 598-605.
47. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Belinger DC, Canfield RL, Dietrich KN, Bornschein R, Greeme T, Rothenberg SJ, Needleman HL, Schnaas L, Wasserman G, Graziano J, Roberts R (2005). Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environmental Health Perspectives 113, 894-899.
48. Lebert F, Pasquier F, Petit H (1995). Personality traits and frontal lobe dementia. International Journal of Geriatric Psychiatry 10, 1047-1049.
49. Leentjens AFG, van der Mast RC (2005). Delirium in elderly people: an update. Current Opinion in Psychiatry 18, 325-330.
50. 4th edn. Oxford University Press: Oxford.
51. Lezak MD, Howieson DB, Loring DW (2004). Neuropsychological Assessment, 4th edn. Oxford University Press: Oxford. Li Y, Grupe A (2007). Genetics of late-onset Alzheimer's disease: progress and prospect. Pharmacogenomics 8, 1747-1755.
52. Lishman WA (1998). Organic Psychiatry: The Psychologica. Psychologica of Cerebral Disorder, 3rd edn. Blackwell Science: Oxford.
53. Low LF, Brodaty H, Draper B (2002). A study of premorbid personality and behavioural and psychological symptoms of dementia in nursing home residents. International Journal of Geriatric Psychiatry 17, 779-783.
54. Lyketsos C (2006). Lessons from neuropsychiatry. Journal of Neuropsychiatry and Clinical Neurosciences 18, 445-449.
55. Marin DB, Breuer B, Marin ML, Silverman J, Schmeidler J, Greenberg D, Flynn S, Mare M, Lantz M, Libow L, Neufeld R, Altstiel L, Davis KL, Mohs RC (1998). The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis 140, 173-180.
56. McCusker J, Cole M, Dendukuri N, Han L, Belzile E (2003). The course of delirium in older medical inpatients: a prospective study. Journal of General Internal Medicine 18, 696-704.
57. Meins W, Dammast J (2000). Do personality traits predict the occurrence of Alzheimer's disease? International Journal of Geriatric Psychiatry 15, 120-124.
58. Meins W, Frey A, Thiesemann R (1998). Premorbid personality traits in Alzheimer's disease: do they predispose to noncognitive behavioral symptoms? International Psychogeriatrics 10, 369-378.
59. Morrison JH, Hof PR (1997). Life and death of neurons in the aging brain. Science 278, 412-419.
60. Nathoo N, Chetty R, van Dellen JR, Barnett GH (2003). Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E. Molecular Pathology 56, 132-136.
61. Otto M, Esselmann H, Schulz-Schaeffer W, Neumann M, Schroter A, Ratzka P, Cepek L, Zerr I, Steinacker P, Windl O, Kornhuber J, Kretzschmar HA, Poser S, Wiltfang J (2000). Decreased b-amyloid 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurology 54, 1099-1102.
62. Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser S (1997). Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neuroscience Letters 225, 210-212. (Pubitemid 27191632)
63. Pankratz N, Byder L, Halter C, Rudolph A, Shults CW, Conneally PM, Foroud T, Nichols WC, the Parkinson Study Group-PROGENI Investigators (2006). Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Movement Disorders 21, 45-49.
64. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AAF, Trojanowski JQ, Petersen RB, Gambetti P (1996). Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Annals of Neurology 39, 767-778.
65. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999). Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Annals of Neurology 46, 224-233.
66. Petersen RC, Morris JC (2005). Mild cognitive impairment as a clinical entity and a treatment target. Archives of Neurology 62, 1160-1163.
67. Prusiner SB, DeArmond SJ (1994). Prion diseases and neurodegeneration. Annual Review of Neuroscience 17, 311-339.
68. Quinette P, Guillery-Girard B, Dayan J, de la Sayette V, Marquis S, Viader F, Desgranges B, Eustache F (2006). What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain 129, 1640-1658.
69. Riepe MW, Adler G, Ibach B, Weinkauf B, Tracik F, Gunay I (2007). Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine. Dementia and Geriatric Cognitive Disorders 23, 301-306.
70. Robins E, Guze SB (1970). Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry 126, 107-111.
71. Rockwood K, Cosway S, Carver D, Jarrett P, Stadnyk K, Fisk J (1999). The risk of dementia and death after delirium. Age and Ageing 28, 551-556.
72. Ropacki SA, Jeste DV (2005). Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. American Journal of Psychiatry 162, 2022-2030.
73. Sachdev P (1996). A critique of 'organic' and its proposed alternatives. Australian and New Zealand Journal of Psychiatry 30, 165-170.
74. Sachdev P (2000). Is it time to retire the term 'dementia'? Journal of Neuropsychiatry and Clinical Neurosciences 12, 276-279.
75. Schulz JB, Falkenburger BH (2004). Neuronal pathology in Parkinson's disease. Cell and Tissue Research 318, 135-147.
76. Schwartz BS, Bolla KI, Stewart WF, Ford P, Agnew J, Frumkin H (1993). Decrements in neurobehavioral performance associated with mixed exposure to organic and inorganic lead. American Journal of Epidemiology 137, 1006-1021.
77. Siddiqi N, Allan O, Holmes JD (2006). Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age and Ageing 35, 350-364.
78. Slade T, Watson D (2006). The structure of common DSM-IV and ICD-10 mental disorder in the Australian general population. Psychological Medicine 36, 1593-1600.
79. Strakowski SM, DelBello MP, Adler CM (2005). The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular Psychiatry 10, 105-116.
80. Strittmater WJ, Roses A (1996). Apolipoprotein E and Alzheimer's disease. Annual Review of Neuroscience 19, 53-77.
81. Tanzi RE, Kovacs DM, Kim T-W, Moir RD, Guenette SY, Wasco W (1996). The gene defects responsible for familial Alzheimer's disease. Neurobiology of Disease 3, 159-168.
82. Thomas AJ, O'Brien JT, Davis S, Ballard C, Barber R, Kalaria RN, Perry RH (2002). Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Archives of General Psychiatry 59, 785-792.
83. Thomas EA (2006). Striatal specificity of gene expression dysregulation in Huntington's disease. Journal of Neuroscience Research 84, 1151-1164.
84. Tyrrell J, Cosgrave M, McCarron M, McPherson J, Calvert J, Kelly A, McLaughlin M, Gill M, Lawlor BA (2001). Dementia in people with Down's syndrome. International Journal of Geriatric Psychiatry 16, 1168-1174.
85. Valenzuela M, Sachdev P (2006a). Brain reserve and dementia: a systematic review. Psychological Medicine 36, 441-454.
86. Valenzuela M, Sachdev P (2006b). Brain reserve and cognitive decline: a non-parametric systematic review. Psychological Medicine 36, 1065-1073.
87. Van Den Heuvel C, Thornton E, Vink R (2007). Traumatic brain injury and Alzheimer's disease: a review. Progress in Brain Research 161, 303-316.
88. van Everbrock B, Croes EA, Pals P, Dermaut B, Jansen G, van Duijn CM, Cruts M, Van Broeckhoven C, Martin J-J, Cras P (2001). Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob disease phenotype. Neuroscience Letters 313, 69-72. (Pubitemid 32973897)
89. Wang PS, Wu YT, Hung CI, Kwan SY, Teng S, Soong BW (2008). Early detection of periodic sharp wave complexes on EEG by independent analysis in patients with Creutzfeldt-Jakob disease phenotype. Journal of Clinical Neurophysiology 25, 25-31.
90. Wiltfang J, Lewczuk P, Riederer P, Grünblatt E, Hock C, Scheltens P, Hampel H, Vanderstichele H, Iqbal K, Galaasko D, Lannfelt L, Otto M, Esselmann H, Henkel AW, Kornhuber J, Blennow K (2005). Consensus paper of the WFSBP Task Force on biological markers of dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World Journal of Biological Psychiatry 6, 69-84.
91. Wright RO, Baccarelli A (2007). Metals and neurotoxicology. Journal of Nutrition 137, 2809-2813.
92. Young J, Inouye SK (2007). Delirium in older people. British Medical Journal 334, 842-846.
93. Zakzanis KK, Leach L, Kaplan E (1999). Neuropsychological Differential Diagnosis: Studies on Neuropsychology, Development and Cognition. Swets & Zeitlinger: Lisse.
94. Zipursky RB, Meyer JH, Verhoeff NP (2007). PET and SPECT imaging in psychiatric disorders. Canadian Journal of Psychiatry 52, 146-157.